The family business

Merck owes its victory in a recently concluded Vioxx trial in New Jersey largely to the testimony of J. Michael Gaziano, a Harvard cardiologist who expressed his doubts that Vioxx, and not stress, triggered the 2001 heart attack in Frederick "Mike" Humeston, who argued otherwise. It turns out that Gaziano's brother, Todd, a prominent constitutional law scholar at the conservative Heritage Foundation think tank in Washington, DC, h

Written byAdam Marcus
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Merck owes its victory in a recently concluded Vioxx trial in New Jersey largely to the testimony of J. Michael Gaziano, a Harvard cardiologist who expressed his doubts that Vioxx, and not stress, triggered the 2001 heart attack in Frederick "Mike" Humeston, who argued otherwise. It turns out that Gaziano's brother, Todd, a prominent constitutional law scholar at the conservative Heritage Foundation think tank in Washington, DC, has also sat on the defendant's side of a civil courtroom.

Todd Gaziano, a specialist in the judiciary, has done some thinking in the past on tobacco litigation and tort reform ? the latter subject bearing on the Vioxx lawsuits, although he hasn't written specifically on Vioxx. Michael Gaziano had opined in a previous case that he did not see a link between ephedra and heart problems, a view at odds with the Food and Drug Administration, and he said the same about ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies